BIP Capital Partners
Primary Menu
Skip to content
HOME
About us
OUR TEAM
OUR HISTORY
ESG
BIP IV
investment approach
INVESTMENT APPROACH
INVESTMENT CHARACTERISTICS
portfolio
SELECTED INVESTMENTS
SELECTED EXITS
News
CONTACT
Archives
Enzymotec reports 3rd quarter 2014 unaudited financial results
BIP invests in lifebrain AG, an Austrian-based medical diagnostic laboratory group
BIP sells its participation in dcinex
Pinova Capital and BIP acquire Utimaco Software AG in a buyout transaction
BIP participates in the buyout of Socotec France
Posts navigation
← Previous
1
2
BIP Capital Partners